Overview / Abstract: |
Target Audience Program Overview Learning Objectives EVALUATE recent evidence for current and investigational ICIs used in monotherapy and combination regimens for NSCLC |
Expiration |
Aug 17, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
0.25 |
Accreditation |
ACCME, ACPE, ANCC |
Presenters / Authors / Faculty |
Hossein Borghaei, DO, MS |
Sponsors / Supporters / Grant Providers |
Genmab US, Inc., Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme |
Keywords / Search Terms |
Relias LLC Relias, Free CME, non-small cell lung cancer, NSCLC Free CE CME |